Fulminant myocarditis following SARS-CoV-2 mRNA vaccination rescued with venoarterial ECMO: A report of two cases.

Rosa Vila-OlivesAitor UribarriMaría Martínez-MartínezEduard ArgudoCamilo BonillaLuis ChiscanoLorena HerradorAlejandra Gabaldónnull Irene BueraMaria VidalAna De la IglesiaMaria Ángeles DíazElena LópezMarta FontJose A BarrabésJordi RieraIgnacio Ferreira-GonzálezRicard Ferrer

Published in: Perfusion (2023)

COVID-19 vaccine-associated fulminant myocarditis has a high morbidity and mortality but presents a high potential for recovery. V-A ECMO should be established in cases with refractory cardiogenic shock during the acute phase.

Keyphrases

extracorporeal membrane oxygenation
sars cov
acute respiratory distress syndrome
coronavirus disease
respiratory syndrome coronavirus
respiratory failure
liver failure
mechanical ventilation
binding protein